IL4RA多态性与预测慢性阻塞性肺疾病易感性的相关性。

IF 1.9 4区 医学 Q3 PHARMACOLOGY & PHARMACY Pharmacogenomics Pub Date : 2023-07-01 Epub Date: 2023-08-08 DOI:10.2217/pgs-2023-0010
Depanshi Pandit, Parul Sharma, Harsh Yadav, Kranti Garg, Vishal Chopra, Siddharth Sharma
{"title":"IL4RA多态性与预测慢性阻塞性肺疾病易感性的相关性。","authors":"Depanshi Pandit,&nbsp;Parul Sharma,&nbsp;Harsh Yadav,&nbsp;Kranti Garg,&nbsp;Vishal Chopra,&nbsp;Siddharth Sharma","doi":"10.2217/pgs-2023-0010","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> The cytokine IL-4 plays vital role in the intercellular signalling network during immune responses to allergen exposure. <b>Methods:</b> This cross-sectional study involved 202 chronic obstructive pulmonary disease (COPD) patients and 203 healthy individuals. The genotyping of <i>IL4RAQ576R</i> gene polymorphism was determined using PCR restriction fragment length polymorphism analysis. <b>Results:</b> Significant association between mutant genotype (GG) and combined (AA+AG) genotype for the risk of COPD was found (odds ratio [OR]: 4.32; p = 0.04). A significant protective effect was observed between the <i>IL4RAQ576R</i> polymorphism and Global Strategy for Obstructive Lung Disease (GOLD) stage four patients in a recessive model (AA+AG vs GG; p = 0.002). In GOLD A, a substantial relationship was found between the AG and wild-type genotypes (AA) for COPD risk (OR: 2.38; p = 0.03). A strong association was found for COPD duration of 5-10 years (OR: 8.80; p = 0.01). <b>Conclusion:</b> <i>IL4RAQ576R</i> polymorphism is associated with COPD susceptibility.</p>","PeriodicalId":20018,"journal":{"name":"Pharmacogenomics","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association of <i>IL4RA</i> polymorphism in predicting susceptibility toward chronic obstructive pulmonary disease.\",\"authors\":\"Depanshi Pandit,&nbsp;Parul Sharma,&nbsp;Harsh Yadav,&nbsp;Kranti Garg,&nbsp;Vishal Chopra,&nbsp;Siddharth Sharma\",\"doi\":\"10.2217/pgs-2023-0010\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> The cytokine IL-4 plays vital role in the intercellular signalling network during immune responses to allergen exposure. <b>Methods:</b> This cross-sectional study involved 202 chronic obstructive pulmonary disease (COPD) patients and 203 healthy individuals. The genotyping of <i>IL4RAQ576R</i> gene polymorphism was determined using PCR restriction fragment length polymorphism analysis. <b>Results:</b> Significant association between mutant genotype (GG) and combined (AA+AG) genotype for the risk of COPD was found (odds ratio [OR]: 4.32; p = 0.04). A significant protective effect was observed between the <i>IL4RAQ576R</i> polymorphism and Global Strategy for Obstructive Lung Disease (GOLD) stage four patients in a recessive model (AA+AG vs GG; p = 0.002). In GOLD A, a substantial relationship was found between the AG and wild-type genotypes (AA) for COPD risk (OR: 2.38; p = 0.03). A strong association was found for COPD duration of 5-10 years (OR: 8.80; p = 0.01). <b>Conclusion:</b> <i>IL4RAQ576R</i> polymorphism is associated with COPD susceptibility.</p>\",\"PeriodicalId\":20018,\"journal\":{\"name\":\"Pharmacogenomics\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.9000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pharmacogenomics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.2217/pgs-2023-0010\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2023/8/8 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q3\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacogenomics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2217/pgs-2023-0010","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/8/8 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

背景:细胞因子IL-4在对过敏原暴露的免疫反应中在细胞间信号网络中起着至关重要的作用。方法:这项横断面研究涉及202名慢性阻塞性肺病(COPD)患者和203名健康人。应用聚合酶链式反应限制性片段长度多态性分析方法对IL4RAK576R基因多态性进行分型。结果:突变基因型(GG)和联合基因型(AA+AG)与COPD风险显著相关(比值比[OR]:4.32;p=0.04)。在隐性模型中,IL4RAK576R多态性与阻塞性肺病全球策略(GOLD)四期患者之间观察到显著的保护作用(AA+AGvs GG;p=0.002)。在GOLD A中,AG基因型和野生型基因型(AA)与COPD危险性有显著相关性(OR:2.38;p=0.03)。COPD持续时间为5-10年(OR:8.80;p=0.01)。结论:IL4RAK576R多态性与COPD易感性有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Association of IL4RA polymorphism in predicting susceptibility toward chronic obstructive pulmonary disease.

Background: The cytokine IL-4 plays vital role in the intercellular signalling network during immune responses to allergen exposure. Methods: This cross-sectional study involved 202 chronic obstructive pulmonary disease (COPD) patients and 203 healthy individuals. The genotyping of IL4RAQ576R gene polymorphism was determined using PCR restriction fragment length polymorphism analysis. Results: Significant association between mutant genotype (GG) and combined (AA+AG) genotype for the risk of COPD was found (odds ratio [OR]: 4.32; p = 0.04). A significant protective effect was observed between the IL4RAQ576R polymorphism and Global Strategy for Obstructive Lung Disease (GOLD) stage four patients in a recessive model (AA+AG vs GG; p = 0.002). In GOLD A, a substantial relationship was found between the AG and wild-type genotypes (AA) for COPD risk (OR: 2.38; p = 0.03). A strong association was found for COPD duration of 5-10 years (OR: 8.80; p = 0.01). Conclusion: IL4RAQ576R polymorphism is associated with COPD susceptibility.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Pharmacogenomics
Pharmacogenomics 医学-药学
CiteScore
3.40
自引率
9.50%
发文量
88
审稿时长
4-8 weeks
期刊介绍: Pharmacogenomics (ISSN 1462-2416) is a peer-reviewed journal presenting reviews and reports by the researchers and decision-makers closely involved in this rapidly developing area. Key objectives are to provide the community with an essential resource for keeping abreast of the latest developments in all areas of this exciting field. Pharmacogenomics is the leading source of commentary and analysis, bringing you the highest quality expert analyses from corporate and academic opinion leaders in the field.
期刊最新文献
Association of DNA methylation, polymorphism and mRNA level of ALAS1 with antituberculosis drug-induced liver injury. It is time for educators to act: pharmacogenomics education and its implementation into clinical practice. Meta-analysis revisiting the influence of UGT1A1*28 and UGT1A1*6 on irinotecan safety in colorectal cancer patients. A critical review of RAF inhibitors in BRAF-mutated glioma treatment Impact of CYP2D6 and ADRB1 polymorphisms on heart rate of post-PCI patients treated with metoprolol.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1